Press Releases

Sep 14, 2021

Adhera Therapeutics Signs Letter of Intent to Acquire CD71-Targeted Cancer Therapy Paclitaxel Gallium Transferrin

Jan 17, 2022

Adhera Therapeutics Appoints Trond K. Waerness as Chairman of the Board, Company Focuses on Uplist to NASDAQ

Aug 18, 2022

Adhera Therapeutics Names Preeminent Diabetes Pioneer Dr. Jean Buteau to Scientific Advisory Board

Jul 20, 2021

Adhera Therapeutics Announces Uplisting to OTCQB Venture Marketplace

Sep 15, 2021

Adhera Therapeutics Receives Notice of Allowance for New Canadian Patent Covering MLR-1019 for Dyskinesia and Related Disorders

Investor Relations
Financial Statements
Fillings

Corporate Presentation

All the information you need to get started with Adhera

Download Now
In-Depth Information
Market Statistics and Facts
Drug Development Pipeline